DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,260,000 | -9.7% | 1,750,000 | 0.0% | 0.16% | +33.1% |
| Q2 2023 | $24,640,000 | -8.9% | 1,750,000 | 0.0% | 0.12% | -29.5% |
| Q1 2023 | $27,037,500 | +32.0% | 1,750,000 | +40.0% | 0.18% | +8.0% |
| Q4 2022 | $20,487,500 | -11.4% | 1,250,000 | 0.0% | 0.16% | +10.9% |
| Q3 2022 | $23,125,000 | +17.2% | 1,250,000 | -16.7% | 0.15% | +26.7% |
| Q2 2022 | $19,725,000 | +1138.2% | 1,500,000 | +819.7% | 0.12% | +1833.3% |
| Q4 2021 | $1,593,000 | -91.7% | 163,100 | -71.0% | 0.01% | -92.3% |
| Q3 2021 | $19,134,000 | +30.7% | 563,100 | +40.8% | 0.08% | +21.9% |
| Q2 2021 | $14,644,000 | -18.4% | 400,000 | 0.0% | 0.06% | -42.3% |
| Q1 2021 | $17,936,000 | -10.2% | 400,000 | +14.3% | 0.11% | -8.3% |
| Q4 2020 | $19,975,000 | – | 350,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |